In an attempt to show that we can generate more aggressive, SCLC-like tumors from PNECs derived from hESCs, we have added efficiently transcribed MYC oncogenes to cells in which expression of TP53 and RB1 is inhibited by shRNAs. The gene discussed is TP53; the disease is small cell lung carcinoma.